| |
Latest 10 SEC filings (by transaction date) for MRK within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 29/24 | Mar 28/24 | Wendell Peter C | Direct Ownership | Phantom Stock | A - Grant, award or other under Rule 16b-3(d) | 227 | $131.95 |
Mar 29/24 | Mar 28/24 | Seidman Christine E | Direct Ownership | Phantom Stock | A - Grant, award or other under Rule 16b-3(d) | 62 | $131.95 |
Mar 29/24 | Mar 28/24 | Glocer Thomas H | Direct Ownership | Phantom Stock | A - Grant, award or other under Rule 16b-3(d) | 341 | $131.95 |
Mar 29/24 | Mar 28/24 | Coe Mary Ellen | Direct Ownership | Phantom Stock | A - Grant, award or other under Rule 16b-3(d) | 227 | $131.95 |
Feb 15/24 | Feb 14/24 | Litchfield Caroline | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -38,291 | |
Feb 15/24 | Feb 14/24 | Litchfield Caroline | Direct Ownership | Common Stock | S - Open market or private sale | -38,291 | $125.50 |
Feb 15/24 | Feb 14/24 | Litchfield Caroline | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 38,291 | $58.08 |
Feb 15/24 | Feb 14/24 | Davis Robert M | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -85,021 | |
Feb 15/24 | Feb 14/24 | Davis Robert M | Direct Ownership | Common Stock | S - Open market or private sale | -85,021 | $125.40 |
Feb 15/24 | Feb 14/24 | Davis Robert M | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 85,021 | $73.73 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for MRK within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 29/24 | Mar 28/24 | Wendell Peter C | Direct Ownership | Phantom Stock | A - Grant, award or other under Rule 16b-3(d) | 227 | $131.95 |
Mar 29/24 | Mar 28/24 | Seidman Christine E | Direct Ownership | Phantom Stock | A - Grant, award or other under Rule 16b-3(d) | 62 | $131.95 |
Mar 29/24 | Mar 28/24 | Glocer Thomas H | Direct Ownership | Phantom Stock | A - Grant, award or other under Rule 16b-3(d) | 341 | $131.95 |
Mar 29/24 | Mar 28/24 | Coe Mary Ellen | Direct Ownership | Phantom Stock | A - Grant, award or other under Rule 16b-3(d) | 227 | $131.95 |
Feb 15/24 | Feb 14/24 | Litchfield Caroline | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -38,291 | |
Feb 15/24 | Feb 14/24 | Litchfield Caroline | Direct Ownership | Common Stock | S - Open market or private sale | -38,291 | $125.50 |
Feb 15/24 | Feb 14/24 | Litchfield Caroline | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 38,291 | $58.08 |
Feb 15/24 | Feb 14/24 | Davis Robert M | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -85,021 | |
Feb 15/24 | Feb 13/24 | Davis Robert M | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -108,491 | |
Feb 15/24 | Feb 13/24 | Davis Robert M | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -41,509 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Eyepoint Pharmaceuticals (OQ:EYPT) |
AbbVie (N:ABBV) |
Amphastar Pharmaceuticals (OQ:AMPH) |